ACER THERAPEUTICS INC - COM (ACER)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
1,469,088
Share change
-57,455
Total reported value
$3,350,412
Price per share
$2.28
Number of holders
16
Value change
-$159,512
Number of buys
8
Number of sells
10

Institutional Holders of ACER THERAPEUTICS INC - COM (ACER) as of Q4 2021

As of 31 Dec 2021, ACER THERAPEUTICS INC - COM (ACER) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,469,088 shares. The largest 10 holders included Nantahala Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, RENAISSANCE TECHNOLOGIES LLC, RAYMOND JAMES & ASSOCIATES, and TWO SIGMA SECURITIES, LLC. This page lists 16 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.